Perfuze, a leader in next-generation catheter-based technology for the treatment of acute ischemic stroke, today announced ...

Comprehensive Analysis of the Global Clinical Trials IndustryThe global clinical trials sector is experiencing a significant ...

Over the past 5 decades, diversity in gender, racial, and ethnic representation among neurology faculty in the United States has increased; however, these changes are less pronounced among senior ...

clinical, and internship phases) across various universities throughout Ecuador. The study objective was to investigate the relationship between neurophobia and the probability of specializing in ...

according to a study published online April 17 in Stroke. Jukka Putaala, M.D., from Helsinki University Hospital and the University of Helsinki, and colleagues enrolled patients aged 18 to 49 ...

Clinical Quality Language (CQL) is an HL7 specification for the expression of clinical knowledge that can be used within both the Clinical Decision Support (CDS) and Clinical Quality Measurement (CQM) ...

Neurology is a medical specialty that is concerned with the study of structure, function and disorders of the nervous system. Microglia have a central role in the clearance of amyloid-β after imm ...

including Alzheimer disease-related dementia (ADRD), according to a study published online April 1 in the Journal of Neurology, Neurosurgery & Psychiatry. Minwoo Lee, M.D., Ph.D., from Hallym ...

The new findings resemble those from separate clinical trial research published in January in Neurology. That study treated people with hypertension for 3.3 years and followed them for a median of ...

CONCLUSIONS DVAs do not seem to be associated with a specific clinical presentation. In a significant percentage of cases, however, coexisting cavernomas are found which have a defined bleeding ...

Axoft demonstrated the safety and functionality of its novel Fleuron™ material in the operating room, which was also featured in new research that outlines the technology’s clinical ...

Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to ...